Literature DB >> 21337292

[Abdominal vacuum therapy for the open abdomen - a retrospective analysis of 82 consecutive patients].

A J Fieger1, F Schwatlo, D F-X Mündel, M Schenk, F Hemminger, B Kirchdorfer, R Ruppert, N C Nüssler.   

Abstract

BACKGROUND: The therapy for open abdomen remains challenging. Abdominal vacuum therapy seems to simplify the treatment and to enable a direct fascial closure in a high percentage of the patients. PATIENTS AND METHODS: A retrospective analysis of 82 consecutive patients who underwent abdominal vacuum therapy between January 2005 and December 2007 was undertaken. Indications, -duration of treatment, complications as well as rate and type of abdominal wall closure were evaluated.
RESULTS: The 82 consecutive patients consisted of 46 % female and 54 % male patients with a median age of 65.5 years. The most frequent diagnoses were colorectal carcinoma (24 %, n = 28, colon n = 18 and rectum n = 10), inflammatory bowel dis-ease (13 %), perforated peptic ulcer (9 %), necrotising pancreatitis (7 %), peritoneal carcinosis (5 %), ileus (5 %) and mesenteric ischaemia (4 %). The predominant indication for vacuum therapy was peritonitis (88 %). Vacuum therapy treatment was applied for a median of 6 days (range: 1-73 days). 18 patients (22 %) received intraabdominal foam dressings without the fenestrated polyurethane layer. In 70 % of all cases the abdominal vacuum therapy was performed without complications. 16 patients (19.5 %) developed intestinal fistulas. However, fistulas were not observed among the patients who were treated with foam dressings without a polyurethane layer. Abdominal bleeding was observed in 8 patients (10 %) and a persistent abdominal compartment syndrome was seen in one patient. Nine patients (11 %) died during hospitalisation. After completion of the intraabdominal vacuum therapy, -direct fascial closure was feasible in 35 patients (43 %). In 47 patients (57 %) an absorbable synthetic mesh was required for fascial closure. Symptomatic incisional hernias -occurred in 22 % of the patients.
CONCLUSION: Abdominal vacuum therapy simplifies the treatment of patients with abdominal catastrophes such as peritonitis or necrotising pancreatitis. The cost-effective intraperitoneal use of a foam dressing without a fenestrated polyurethane layer was possible without an increased rate of fistulas. This retrospective analysis demonstrates that abdominal vacuum therapy can be performed without complications in the majority of patients. Furthermore, direct fascial closure is possible in almost half of the patients. © Georg Thieme Verlag Stuttgart ˙ New York.

Entities:  

Mesh:

Year:  2011        PMID: 21337292     DOI: 10.1055/s-0030-1247376

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  8 in total

Review 1.  EHS clinical guidelines on the management of the abdominal wall in the context of the open or burst abdomen.

Authors:  M López-Cano; J M García-Alamino; S A Antoniou; D Bennet; U A Dietz; F Ferreira; R H Fortelny; P Hernandez-Granados; M Miserez; A Montgomery; S Morales-Conde; F Muysoms; J A Pereira; R Schwab; N Slater; A Vanlander; G H Van Ramshorst; F Berrevoet
Journal:  Hernia       Date:  2018-09-03       Impact factor: 4.739

2.  Outcome of negative-pressure wound therapy for open abdomen treatment after nontraumatic lower gastrointestinal surgery: analysis of factors affecting delayed fascial closure in 101 patients.

Authors:  Claus Anders Bertelsen; Rasmus Fabricius; Jakob Kleif; Bent Kristensen; Ismail Gögenur
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

Review 3.  Systematic review and meta-analysis of the open abdomen and temporary abdominal closure techniques in non-trauma patients.

Authors:  J J Atema; S L Gans; M A Boermeester
Journal:  World J Surg       Date:  2015-04       Impact factor: 3.352

4.  [The treatment of acute secondary peritonitis : A retrospective analysis of the use of continuous negative pressure therapy].

Authors:  V Müller; G Koplin; J Pratschke; W Raue
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-05-29       Impact factor: 0.840

5.  Incisional hernia rate after open abdomen treatment with negative pressure and delayed primary fascia closure.

Authors:  A Brandl; E Laimer; A Perathoner; M Zitt; J Pratschke; R Kafka-Ritsch
Journal:  Hernia       Date:  2013-03-02       Impact factor: 4.739

Review 6.  The role of open abdomen in non-trauma patient: WSES Consensus Paper.

Authors:  Federico Coccolini; Giulia Montori; Marco Ceresoli; Fausto Catena; Ernest E Moore; Rao Ivatury; Walter Biffl; Andrew Peitzman; Raul Coimbra; Sandro Rizoli; Yoram Kluger; Fikri M Abu-Zidan; Massimo Sartelli; Marc De Moya; George Velmahos; Gustavo Pereira Fraga; Bruno M Pereira; Ari Leppaniemi; Marja A Boermeester; Andrew W Kirkpatrick; Ron Maier; Miklosh Bala; Boris Sakakushev; Vladimir Khokha; Manu Malbrain; Vanni Agnoletti; Ignacio Martin-Loeches; Michael Sugrue; Salomone Di Saverio; Ewen Griffiths; Kjetil Soreide; John E Mazuski; Addison K May; Philippe Montravers; Rita Maria Melotti; Michele Pisano; Francesco Salvetti; Gianmariano Marchesi; Tino M Valetti; Thomas Scalea; Osvaldo Chiara; Jeffry L Kashuk; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2017-08-14       Impact factor: 5.469

7.  Chinese Trauma Surgeon Association for management guidelines of vacuum sealing drainage application in abdominal surgeries-Update and systematic review.

Authors:  Yang Li; Pei-Yuan Li; Shi-Jing Sun; Yuan-Zhang Yao; Zhan-Fei Li; Tao Liu; Fan Yang; Lian-Yang Zhang; Xiang-Jun Bai; Jing-Shan Huo; Wu-Bing He; Jun Ouyang; Lei Peng; Ping Hu; Yan-An Zhu; Ping Jin; Qi-Feng Shao; Yan-Feng Wang; Rui-Wu Dai; Pei-Yang Hu; Hai-Ming Chen; Ge-Fei Wang; Yong-Gao Wang; Hong-Xu Jin; Chang-Ju Zhu; Qi-Yong Zhang; Biao Shao; Xi-Guang Sang; Chang-Lin Yin
Journal:  Chin J Traumatol       Date:  2019-02-14

8.  Negative pressure wound therapy for the treatment of the open abdomen and incidence of enteral fistulas: a retrospective bicentre analysis.

Authors:  Sven Richter; Stefan Dold; Johannes P Doberauer; Peter Mai; Jochen Schuld
Journal:  Gastroenterol Res Pract       Date:  2013-10-28       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.